The existing University of Missouri Research Reactor (MURR) is the only U.S. producer of four critical radioisotopes used in the treatment of liver, thyroid, pancreatic and prostate cancers, and in imaging agents to diagnose cancers and heart disease. Our nation has an acute need to expand its supply of radioisotopes as more are used in successful cancer treatments, and NextGen MURR will build on the university’s history of lifesaving endeavors.Learn More About MURR
cancer and cardiac patients are treated each year with radioisotopes produced at MURR.
of thyroid cancer patients are cured after using radioisotopes. Liver, prostate and pancreatic cancer patients have a better quality of life and live longer with radioisotope treatment.
of safe, innovative history. Operating 24 hours a day, 6.5 days a week, 52 weeks a year — MURR is the most powerful university research reactor in the U.S., working at 10 megawatts.
MURR’s functional life is limited. Without a new reactor, these critical radioisotopes may not be available in the U.S. in the future, leading to dependency on foreign sources of radioisotopes. Missouri can be the center for nuclear medicine to attract researchers, pharmaceutical firms, investors and distribution facilities. Missouri’s central location ensures a quick deployment of radioisotopes around the country, which is critical due to the short half-life of radioisotopes. NextGen MURR will help secure our domestic supply of radioisotopes to treat Americans.
Matt Sanford named executive director for MURR
July 13, 2023 — University of Missouri President Mun Choi has announced Matt Sanford as executive director for the University of Missouri’s Research Reactor (MURR).
MURR continues to bolster domestic supply chain of radioisotopes
July 13, 2023 — Continuing as an essential leader in domestic isotope production, MURR began production of iron-59 (Fe-59) and manganese-54 (Mn-54) radioisotopes.
MU announces NextGen MURR initiative
March 23, 2023 — The University of Missouri announced today an initiative to build a new, larger research reactor that will expand critical cancer-fighting research and medical isotope production at MU.